![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 58.72 | ACUITE BBB- | Stable | Upgraded | - |
Total Outstanding | 58.72 | - | - |
Total Withdrawn | 0.00 | - | - |
Rating Rationale |
Acuite has upgraded its long-term rating to 'ACUITE BBB-' (read as ACUITE triple B minus) from 'ACUITE BB+' (read as ACUITE double B plus) on Rs.58.72 Cr. bank facilities of Neemuch Proteins LLP (NPLLP). The outlook remains 'Stable'.
Rationale for rating NPLLP had appealed the rating reaffirmation on the existing bank facilities to it on September 22, 2025, and had provided incremental information based on which the rating is being upgraded. The information provided clarity about the sustainability of the scale of operations in medium term as evident from the better realizations and increase in volumes. The upgrade in the rating takes into account the operational performance albeit moderation in revenues during FY25. The rating gets comfort from healthy financial risk profile and adequate liquidity with efficient working capital cycle. The firm is currently expanding into edible segment like soya flax, soya flour and others for human consumption that is expected to enhance the scale of operations both in terms of revenue and profitability by FY27. Infusion of capital to support this expansion plan will remain monitorable factor. The additional information provided that the firm is in process of converting into private limited company and approval of Registrar of Companies (ROC) was in place on 6th October 2025. However, the rating is constraint from intense competition and fluctuating prices of the raw materials which may vary in scale of operations. |
About the Company |
Madhya Pradesh Based, Neemuch Proteins LLP (NPLLP) was established in 2020 and the commercial production started in the month of November 2022. It is engaged in Extraction of Soya Crude oil from soyabean and refining of the extracted crude oil further. Currently Mrs. Madhu Bala Patidar, Mr. Dheeraj Kumar Modi, Mr. Omprakash Agrawal, Mr. Sanjay Kumar Agarwal, Mr. Kamal Kumar Modi, Mr. Kalyani Patidar and Mr. Sandeep Modi are the partners of the company.
|
Unsupported Rating |
Not Applicable |
Analytical Approach |
Acuite has considered standalone business and financial risk profile of NPLLP to arrive at the rating. |
Key Rating Drivers |
Strengths |
Healthy Financial Risk profile The firm has healthy financial risk profile marked by improving net worth, gearing below unity and comfortable debt protection metrics. The total tangible net worth improved & stood at Rs.40.38 Cr. as on 31 March 2025 as against Rs. 28.99 Cr. as on 31 March 2024 on the account of accretion of profits into reserves and unsecured loans of Rs.7.00 Cr. has been converted into equity. The gearing improved & stood at below unity at 0.29 times in FY25 as against 1.57 times in FY24. The firm have expansion plans of around Rs. 40.00 Cr. (funded by debt to equity of 5:3 ratio) into edible segment for human consumption that is expected to enhance the scale of operations both in terms of revenue and profitability by FY27. Infusion of capital remains a key monitorable factor. The Total outside liabilities to total net worth (TOL/TNW) stood at 0.69 times as on FY2025 compared to 1.89 times as on FY2024. The debt protection metrics of the company are comfortable marked by interest coverage ratio which stood at 4.12 times for FY2025 as against 3.74 times in FY2024 and Debt Service Coverage Ratio stood at 2.41 times in FY2025 as compared to 2.84 times in FY2024. Acuité believes that going forward, the financial risk profile will continue to remain on similar lines despite debt funded capex plans. Efficient working capital cycle The working capital cycle was efficient as reflected from GCA days of 19 days in FY2025 as against 21 days in FY2024. Inventory days stood at 15 days in FY2025 as against 14 days in FY2024. The firm has to maintain stock of soyabeans for minimum of 7-8 days depending on the price of raw materials. Debtor days stood at 3 days in FY2025 as compared to 4 days in FY2024. The credit terms with customers are ~8 days for DOC and crude oil. The edible oil is accepted on cash basis. Further, Creditor days stood at 7 days in FY2025 as compared to 4 days in FY2024. The credit terms with suppliers are ~5 days. Acuite believes that the working capital cycle is likely to remain at similar levels over the medium term on the account of nature of operations. |
Weaknesses |
Exposure to intense competition |
Rating Sensitivities |
Movement in operating income and profitability margins Committed Infusion of funds by partners to support expansion Timely completion of debt funded capex plan |
Liquidity Position |
Adequate |
The firm’s liquidity position is adequate marked by net cash accruals of Rs. 9.28 Cr. in FY 2025 as against long-term debt obligation of Rs. 1.64 Cr. over the same period. The firm has also made a prepayment of a portion of debt in FY25. The current ratio stood comfortable at 2.07 times as on March 31, 2025, as against 1.62 times as on March 31, 2024. Further, the average maximum bank limit utilization of fund-based for last six months ended July 2025 was 57%. The cash and bank balance of the firm stood at Rs.0.41 Cr. as on March 31, 2025. The management also has flexibility to infuse funds in the business as and when required. The firm have expansion plans of around Rs. 40.00 Cr. (funded by debt to equity of 5:3 ratio) into edible segment for human consumption that is expected to enhance the scale of operations both in terms of revenue and profitability by FY27. Infusion of capital remains a key monitorable factor. The working capital cycle was efficient as reflected from GCA days of 19 days in FY2025 as against 21 days in FY2024. Acuite believes that going forward the firm will maintain adequate liquidity position due to sufficient accruals against debt repayment, moderate current ratio, and moderate reliance on bank limit for funding working capital requirements albeit capex plans. |
Outlook: Stable |
|
Other Factors affecting Rating |
None |
Particulars | Unit | FY 25 (Actual) | FY 24 (Actual) |
Operating Income | Rs. Cr. | 765.44 | 872.93 |
PAT | Rs. Cr. | 4.73 | 6.18 |
PAT Margin | (%) | 0.62 | 0.71 |
Total Debt/Tangible Net Worth | Times | 0.29 | 1.57 |
PBDIT/Interest | Times | 4.12 | 3.74 |
Status of non-cooperation with previous CRA (if applicable) |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||
|
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |